SCHEMBL31049154

SCHEMBL31049154

Cc1c(Cl)nc(Cl)c2cnc(Cl)c(F)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31049176 0.76 — —
SCHEMBL24778050 0.74 L3MBTL1 (0.33) —
SCHEMBL31048879 0.73 DAO (0.35) —
SCHEMBL24663931 0.71 DAO (0.30) —
SCHEMBL22220077 0.70 — —
SCHEMBL31049187 0.69 — —
SCHEMBL22859541 0.67 CCR1 (0.38) —
SCHEMBL31410007 0.67 DAO (0.37) —
SCHEMBL29368111 0.67 CCR1 (0.38) —
SCHEMBL24536757 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024167922-A2 HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-08-15 — — WO disclosed
Send feedback